Tillman Gerngross & Charles Hutchinson
Biotech Goes Boom When Tillman U. Gerngross, 43, and Charles E. Hutchinson, 70, two Dartmouth College professors, started a little biotech company called Glycofi about six years ago, they set about developing a yeast-based technology that could serve as a platform for vaccines and cancer-fighting drugs. This year their company was purchased by pharmaceutical giant Merck for $400 million — the largest cash acquisition by a private company in the history of biotech. Neither is retiring, though. Hutchinson remains a teacher at the Thayer School of Engineering; Gerngross is planning to start some new companies. “The joke is that the way to make a small fortune in biotech is to start with a large fortune,” says Gerngross. “I’m interested in reversing that.”
New Hampshire Magazine knows where "It" is at. Each November, we identify the state's most happening people and publish their names and profiles in our annual "It List."
So what defines an "It" Person?